PMID- 34679472 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20211026 IS - 2075-4418 (Print) IS - 2075-4418 (Electronic) IS - 2075-4418 (Linking) VI - 11 IP - 10 DP - 2021 Sep 26 TI - Association of Adiponectin, Leptin and Resistin Plasma Concentrations with Echocardiographic Parameters in Patients with Coronary Artery Disease. LID - 10.3390/diagnostics11101774 [doi] LID - 1774 AB - The imbalanced network of adipokines may contribute to the development of systemic low-grade inflammation, metabolic diseases and coronary artery disease (CAD). In the last decade, three classic adipokines-adiponectin, leptin and resistin-have been of particular interest in studies of patients with CAD due to their numerous properties in relation to the cardiovascular system. This has directed our attention to the association of adipokines with cardiac structure and function and the development of heart failure (HF), a common end effect of CAD. Thus, the purpose of this study was to analyse the associations of plasma concentrations of adiponectin, leptin and resistin with parameters assessed in the echocardiographic examinations of CAD patients. The presented study enrolled 167 Caucasian patients (133 male; 34 female) with CAD. Anthropometric, echocardiographic and basic biochemical measurements, together with plasma concentrations of adiponectin, leptin and resistin assays, were performed in each patient. Adiponectin concentrations were negatively associated with left ventricular ejection fraction (LVEF) and shortening fraction (LVSF), and positively associated with mitral valve E/A ratio (E/A), left ventricular end-diastolic volume (LVEDV), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter LVESD, and left atrium diameter (LAD). Resistin concentrations were negatively associated with E/A. Leptin concentrations, although correlated with HF severity assessed by the New York Heart Association (NYHA) Functional Classification, were not independently associated with the echocardiographic parameters of cardiac structure or function. In conclusion, adiponectin and resistin, but not leptin, are associated with the echocardiographic parameters of cardiac remodelling and dysfunction. These associations suggest that adiponectin and resistin might be involved in mechanisms of cardiac remodelling or compensative response. We also suggest the possible benefits of adiponectin and resistin level measurements in the monitoring of patients with CAD. FAU - Puchalowicz, Kamila AU - Puchalowicz K AUID- ORCID: 0000-0001-8109-7112 AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70111 Szczecin, Poland. FAU - Kloda, Karolina AU - Kloda K AUID- ORCID: 0000-0003-0395-9826 AD - Medfit Karolina Kloda, 70240 Szczecin, Poland. FAU - Dziedziejko, Violetta AU - Dziedziejko V AUID- ORCID: 0000-0003-4809-415X AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70111 Szczecin, Poland. FAU - Rac, Monika AU - Rac M AUID- ORCID: 0000-0003-1561-346X AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70111 Szczecin, Poland. FAU - Wojtarowicz, Andrzej AU - Wojtarowicz A AD - Department of Cardiology, Pomeranian Medical University, 70111 Szczecin, Poland. FAU - Chlubek, Dariusz AU - Chlubek D AUID- ORCID: 0000-0003-4497-4395 AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70111 Szczecin, Poland. FAU - Safranow, Krzysztof AU - Safranow K AUID- ORCID: 0000-0001-9415-2758 AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70111 Szczecin, Poland. LA - eng GR - 002/RID/2018/19/Ministry of Science and Higher Education/ PT - Journal Article DEP - 20210926 PL - Switzerland TA - Diagnostics (Basel) JT - Diagnostics (Basel, Switzerland) JID - 101658402 PMC - PMC8534895 OTO - NOTNLM OT - adiponectin OT - adipose tissue OT - cardiac diastolic function OT - cardiac remodelling OT - cardiac systolic function OT - echocardiography OT - heart failure OT - leptin OT - myocardial infarction OT - resistin COIS- The authors declare no conflict of interest. EDAT- 2021/10/24 06:00 MHDA- 2021/10/24 06:01 PMCR- 2021/09/26 CRDT- 2021/10/23 01:01 PHST- 2021/09/15 00:00 [received] PHST- 2021/09/22 00:00 [accepted] PHST- 2021/10/23 01:01 [entrez] PHST- 2021/10/24 06:00 [pubmed] PHST- 2021/10/24 06:01 [medline] PHST- 2021/09/26 00:00 [pmc-release] AID - diagnostics11101774 [pii] AID - diagnostics-11-01774 [pii] AID - 10.3390/diagnostics11101774 [doi] PST - epublish SO - Diagnostics (Basel). 2021 Sep 26;11(10):1774. doi: 10.3390/diagnostics11101774.